Generation Income Properties Inc.(GIPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GIPR Generation Income Properties Inc.

Trading 12-19 09:49:32 EST

0.7601

+0.0022

+0.29%

High0.7800	Low0.7600	Vol9.54K
Open0.7800	D1 Closing0.7579	Amplitude2.64%
Mkt Cap4.14M	Tradable Cap3.41M	Total Shares5.45M
T/O7.32K	T/O Rate0.21%	Tradable Shares4.48M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GIPR","market":"US","secType":"STK","nameCN":"Generation Income Properties Inc.","latestPrice":0.7601,"timestamp":1766155723144,"preClose":0.7579,"halted":0,"volume":9537,"delay":0,"floatShares":4482929,"shares":5447772,"eps":-1.890643,"marketStatus":"Trading","change":0.0022,"latestTime":"12-19 09:49:32 EST","open":0.78,"high":0.78,"low":0.76,"amount":7318.0433766,"amplitude":0.026389,"askPrice":0.78,"askSize":531,"bidPrice":0.758,"bidSize":12023,"shortable":0,"etf":0,"ttmEps":-1.890643,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766178000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.7579,"preHourTrading":{"tag":"盘前","latestPrice":0.7581,"preClose":0.7579,"latestTime":"08:55 EST","volume":39,"amount":29.565399239999998,"timestamp":1766152557973},"postHourTrading":{"tag":"盘后","latestPrice":0.7645,"preClose":0.7579,"latestTime":"19:17 EST","volume":4795,"amount":3626.2603,"timestamp":1766103442090},"volumeRatio":0.71885},"requestUrl":"/m/hq/s/GIPR/tweets","defaultTab":"tweets","newsList":[{"id":"1187203221","title":"ASCLETIS-B (01672) Selects Its First Oral GLP-1R/GIPR/GCGR Triple-Target Agonist Peptide ASC37 for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1187203221","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1187203221?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:40","pubTimestamp":1764499221,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that it has selected its first oral GLP-1R/GIPR/GCGR triple-target agonist peptide, ASC37 oral tablets, as a clinical development candidate. The company plans to submit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4144","BK4590","BK1161","GLP","01672","BK1574","BK1515","01477","BK4160","GIPR","BK1191"],"gpt_icon":0},{"id":"2587618791","title":"Ascletis Selects Its First Oral GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2587618791","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2587618791?lang=en_us&edition=fundamental","pubTime":"2025-11-30 18:15","pubTimestamp":1764497700,"startTime":"0","endTime":"0","summary":"- Utilizing Ascletis' Peptide Oral Transport ENhancement Technology , ASC37 oral tablets achieved average absolute oral bioavailability of 4.2%, approximately 9-, 30-, and 60-fold higher than semaglutide, tirzepatide, and retatrutide in the oral SNAC formulation, respectively, in head-to-head non-human primate  studies.- ASC37 oral tablets' drug exposure, as measured by the area under curve , was approximately 57-fold of retatrutide's drug exposure in head-to-head NHP studies.- Average observed half-life of ASC37 oral tablets was approximately 56 hours in NHP studies, supporting once daily and less frequent oral dosing.- ASC37 in vitro activity was approximately 5-, 4- and 4-fold more potent than retatrutide for GLP-1R, GIPR and GCGR, respectively.- Submission of an Investigational New Drug Application  to the U.S. Food and Drug Administration  for ASC37 oral tablets is expected in the second quarter of 2026.\"Selection of ASC37, a promising oral GLP-1R/GIPR/GCGR triple peptide agonist,","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-selects-its-first-oral-glp-1rgiprgcgr-triple-peptide-agonist-asc37-for-clinical-development-302628540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4590","BK4160","BK7095","BK7104","BK4144","IND","AUC.AU","GLP","IND.AU"],"gpt_icon":0},{"id":"2584728936","title":"Generation Income Q3 FFO $0.03 Beats $(0.08) Estimate, Sales $2.470M Beat $2.432M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2584728936","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584728936?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:41","pubTimestamp":1763415706,"startTime":"0","endTime":"0","summary":"Generation Income (NASDAQ:GIPR) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 137.5 percent. This is a 50 percent increase over earnings of $0.02 per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48912032/generation-income-q3-ffo-0-03-beats-0-08-estimate-sales-2-470m-beat-2-432m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Generation Income Q3 FFO $0.03 Beats $(0.08) Estimate, Sales $2.470M Beat $2.432M Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2584108674","title":"Generation Income Properties Reports Q3 2025 Financial and Operating Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2584108674","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584108674?lang=en_us&edition=fundamental","pubTime":"2025-11-18 05:30","pubTimestamp":1763415022,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc.  announced its financial and operating results for the third quarter ended September 30, 2025. Approximately 60% of the company's portfolio annualized rent was derived from tenants with an investment grade credit rating of \"BBB-\" or better. The company's largest tenants-General Services Administration, Dollar General, EXP Services, Kohl's Corporation, and the City of San Antonio-accounted for approximately 59% of the portfolio's annualized base rent as of September 30, 2025. Management highlighted ongoing efforts to reposition the portfolio and reduce preferred equity exposure, citing successful asset management strategies. Notably, the company reported the profitable sale of its only vacant property, which was sold at a gain relative to its purchase price from three years prior, despite the property being vacant at the time of sale. The company emphasized the strength of its asset base and the creditworthiness of its tenants as key components of its ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL7bx3G4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4504","DG","BK4160","BK4547","GIPR","BK4114","LU1430594728.SGD","BK4155","BK4585","KSS","LU1989763690.USD","LU1585245621.USD","BK4220","LU1989763427.SGD","BK4103"],"gpt_icon":0},{"id":"1162352611","title":"ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1162352611","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162352611?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:36","pubTimestamp":1762990584,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that its monthly-dose next-generation amylin receptor agonist ASC36 and GLP-1R/GIPR dual-target agonist ASC35 combination therapy has entered clinical development. The...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK4144","BK4160","BK4590","BK1191","BK1515","BK1574","GLP","01477","GIPR","BK1161"],"gpt_icon":0},{"id":"2583841945","title":"Ascletis Announces Co-formulation of ASC36, Once-Monthly Next-Generation Amylin Receptor Agonist and ASC35, Once-Monthly Next-Generation GLP-1R/GIPR Dual Agonist for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2583841945","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583841945?lang=en_us&edition=fundamental","pubTime":"2025-11-13 07:30","pubTimestamp":1762990200,"startTime":"0","endTime":"0","summary":"- Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly subcutaneously administered GLP-1R/GIPR dual peptide agonist, demonstrated a comparable pharmacokinetic  profile to ASC36 and ASC35 dosed alonein head-to-head non-human primate studies.- ASC36 monotherapy demonstrated approximately 32% greater relative body weight reduction compared to eloralintide monotherapy in a head-to-head diet-induced obese  rat study, while ASC35 monotherapy demonstrated approximately 71% greater relative body weight reduction compared to tirzepatide monotherapy in a head-to-head DIO mouse study.- Co-formulation of ASC36 and ASC35 had excellent chemical and physical stability with no aggregation or precipitation caused by fibrillation at neutral pH.HONG KONG, Nov. 13, 2025 /PRNewswire/ -- Ascletis Pharma Inc.  announces the co-formulation of ASC36, a once-monthlynext-gen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ascletis-announces-co-formulation-of-asc36-once-monthly-next-generation-amylin-receptor-agonist-and-asc35-once-monthly-next-generation-glp-1rgipr-dual-agonist-for-clinical-development-302613467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","IND.AU","PK","BK4590","BK4218","BK7095","GIPR","BK4181","BK4144","BK4160"],"gpt_icon":0},{"id":"2582800511","title":"Press Release: Terns Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2582800511","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582800511?lang=en_us&edition=fundamental","pubTime":"2025-11-11 05:05","pubTimestamp":1762808700,"startTime":"0","endTime":"0","summary":"Unprecedented Phase 1 CML efficacy data and potential best-in-disease profile of TERN-701 featured in ASH 2025 abstract. Upcoming ASH oral presentation to feature expanded and updated dataset from CARDINAL trial. Cash, cash equivalents and marketable securities of $295 million, expected to provide runway into 2028. FOSTER CITY, Calif., Nov. 10, 2025  -- Terns Pharmaceuticals, Inc.  , a clinical-stage oncology company, today reported financial results for the third quarter ended September 30, 2025, and provided corporate updates.TERN-701: Novel investigational allosteric BCR::ABL1 inhibitor for chronic myeloid leukemia . -- In November 2025, Terns announced that an abstract with updated data from. the ongoing Phase 1 CARDINAL trial evaluating TERN-701 in patients with. -- The abstract reported data from the ongoing dose escalation and dose. expansion parts of the CARDINAL trial. Highlights include from the. -- Overall  major molecular response  rate of 75% by. 24 weeks, with 64% achievi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","TERN","BK4160","BK4007"],"gpt_icon":0},{"id":"2581355832","title":"Generation Income Properties Inc Announces Date for Upcoming Stockholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581355832","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581355832?lang=en_us&edition=fundamental","pubTime":"2025-11-08 06:16","pubTimestamp":1762553801,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced that its 2025 Annual Meeting of Stockholders will be held on December 19, 2025, at Foley & Lardner LLP, 100 North Tampa Street, Suite 2700, Tampa, Florida. During the meeting, management will provide a report on the company's operations and achievements over the past year. Stockholders will also vote on matters presented for approval at the Annual Meeting.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 07, 2025, and is solely responsible for the informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nNDL8VPCKN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"2581808394","title":"Generation Income Properties Sells Vacant Florida Industrial Property for $1.95 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581808394","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581808394?lang=en_us&edition=fundamental","pubTime":"2025-11-06 06:26","pubTimestamp":1762381579,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced the sale of its former Irby Construction-occupied industrial property at 702 Tillman Place in Plant City, Florida. The property, which was vacant at the time of sale, was sold for $1,950,000 in cash.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL4xQSdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","LU1974910355.USD","LU1917777945.USD","LU2265009873.SGD","LU1093756168.USD","BK4129","LU2394011477.USD","LU2023250504.SGD","LU1093756325.SGD","LU2237438978.USD","PWR","LU1261432733.SGD","GIPR","LU2106854487.HKD","BK4588","LU1804176565.USD","BK4585","BK4567","LU2023250843.SGD"],"gpt_icon":0},{"id":"2580416946","title":"Generation Income Properties Extends Promissory Note Maturity to December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2580416946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580416946?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:31","pubTimestamp":1761942664,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced an agreement to extend the maturity date of a secured promissory note with Brown Family Enterprises LLC to December 15, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDL5Fxs2c:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"1155542043","title":"Hengrui's Class 1 Innovative Drug HRS-4729, a GLP-1R/GIPR/GCGR Triple Receptor Agonist, Receives Clinical Trial Approval for Metabolic Associated Fatty Liver Disease/Metabolic Associated Steatohepatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1155542043","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155542043?lang=en_us&edition=fundamental","pubTime":"2025-09-12 20:01","pubTimestamp":1757678464,"startTime":"0","endTime":"0","summary":"Recently, Hengrui Pharmaceutical and its subsidiary Fujian Shengdi Pharmaceutical Co., Ltd. received the \"Clinical Trial Approval Notice\" issued by the National Medical Products Administration,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLP","BK1161","BK1574","BK4160","159992","BK4144","GIPR","06978","BK4590"],"gpt_icon":0},{"id":"2561400783","title":"Generation Income Properties Inc. Faces Potential Delisting from Nasdaq Due to Non-Compliance with Equity Requirements","url":"https://stock-news.laohu8.com/highlight/detail?id=2561400783","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561400783?lang=en_us&edition=fundamental","pubTime":"2025-08-23 04:26","pubTimestamp":1755894371,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has been notified by The Nasdaq Stock Market LLC that it is not in compliance with the minimum stockholders' equity requirement necessary for continued listing on The Nasdaq Capital Market. The company's reported stockholders' equity deficit of $965,694 falls short of the required $2.5 million. Additionally, it does not meet alternative listing standards, such as having a market value of listed securities of at least $35 million or reporting net income of at least $500,000 in recent fiscal years. The company's stock will continue to trade under the symbol \"GIPR\" while it works to submit a compliance plan by October 3, 2025. If approved, Nasdaq may grant a further 180 days to meet requirements. Failure to comply could lead to a delisting notice, with the company having the option to request a hearing to stay delisting actions.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250822:nNDL6KsTHP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"2561195416","title":"David Sobelman, Chairman, President, and CEO, Reports Acquisition of Common Shares in Generation Income Properties Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2561195416","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561195416?lang=en_us&edition=fundamental","pubTime":"2025-08-22 04:32","pubTimestamp":1755808373,"startTime":"0","endTime":"0","summary":"David Sobelman, Chairman, President, and CEO of Generation Income Properties Inc, reported an acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 21, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250821:nNDL82k9kK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"2561481188","title":"Generation Income Properties Secures Early Lease Extension with Best Buy, Increasing Rent and Reinforcing Commitment","url":"https://stock-news.laohu8.com/highlight/detail?id=2561481188","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2561481188?lang=en_us&edition=fundamental","pubTime":"2025-08-21 04:31","pubTimestamp":1755721882,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc.  has announced a successful long-term lease extension with Best Buy Stores, L.P.  at its property in Grand Junction, Colorado. The extension, executed through a Second Amendment to Lease, adds five years to the existing lease, now extending from April 1, 2027, through March 31, 2032. Best Buy has also been granted two additional five-year renewal options. The amendment increases the annual rent to approximately $376,087 starting April 1, 2027, representing a rise from the current rent of about $353,061. This extension underscores Best Buy's commitment to the location and enhances the stability of Generation Income Properties' portfolio, aligning with their investment strategy of maintaining well-located real estate occupied by investment-grade tenants.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nNDL8wPpqr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0942090050.USD","BK4533","BK4160","BBY","BK4567","BK4585","LU0868494617.USD","BK4076","LU0868494708.USD","GIPR"],"gpt_icon":0},{"id":"1188128810","title":"ASCLETIS-B (01672): ASC47 Combined with GLP-1R/GIPR Dual Receptor Agonist Peptide ASC31 Demonstrates Superior Weight Loss Effects Compared to ASC47 Plus Tirzepatide Combination in Obese Animal Models","url":"https://stock-news.laohu8.com/highlight/detail?id=1188128810","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188128810?lang=en_us&edition=fundamental","pubTime":"2025-08-18 08:30","pubTimestamp":1755477023,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) announced that the company's directors have disclosed encouraging preclinical efficacy results for the combination of ASC47, a first-in-class weight loss candidate drug for obesity...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1191","GLP","01477","BK1515","GIPR","01672","BK1574","BK4160","BK4144","BK4590"],"gpt_icon":0},{"id":"2559147489","title":"Generation Income Properties Inc. Delays Filing of Q2 2025 Financial Report Due to Debt Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2559147489","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559147489?lang=en_us&edition=fundamental","pubTime":"2025-08-15 21:20","pubTimestamp":1755264042,"startTime":"0","endTime":"0","summary":"Generation Income Properties Inc. has announced a delay in filing its Quarterly Report on Form 10-Q for the period ended June 30, 2025. The company cited the need for additional time to analyze matters related to the loss on extinguishment of debt from its May 2025 CMBS debt financing payoff. Generation Income Properties expects to file the report within five calendar days of the due date. The company reported a total revenue of $4.8 million for the six-months ended June 30, 2025, compared to $4.5 million for the same period last year, with a net loss of $7.1 million, up from $5.1 million the previous year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Generation Income Properties Inc published the original content used to generate th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250815:nNDL9TR7v8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2559981434","title":"Generation Income Properties' Subsidiary Secures Year-Long Extension of Preferred Equity Maturity","url":"https://stock-news.laohu8.com/highlight/detail?id=2559981434","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559981434?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:18","pubTimestamp":1755116317,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc., through its operating partnership Generation Income Properties, L.P., has successfully extended the maturity date of the preferred equity for its joint venture affiliate, GIP VB SPE, LLC, by one year. This extension, one of two pre-negotiated options, was achieved by complying with specific underwriting covenants outlined in the original agreement made in 2023. This strategic move not only strengthens the affiliate's short-term capital structure but also enhances Generation Income Properties' operational flexibility. The company remains focused on long-term value creation for its shareholders and continues discussions on fully recapitalizing the preferred equity.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or lega","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL72SpJ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIPR","BK4160"],"gpt_icon":0},{"id":"2557312059","title":"Terns Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2557312059","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557312059?lang=en_us&edition=fundamental","pubTime":"2025-08-06 04:05","pubTimestamp":1754424300,"startTime":"0","endTime":"0","summary":"Phase 1 trial of TERN-701 in chronic myeloid leukemia (CML) enrolling well; efficacy and safety data including 6-month major molecular response (MMR) rates expected in 4Q25 Phase 2 trial of TERN-601 f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/05/3127816/0/en/Terns-Pharmaceuticals-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","BK4007","GIPR","TERN"],"gpt_icon":0},{"id":"2548010262","title":"Generation Income Properties Inc. Announces Strategic Alternatives and Recapitalization Efforts Amid Market Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2548010262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548010262?lang=en_us&edition=fundamental","pubTime":"2025-07-01 04:30","pubTimestamp":1751315440,"startTime":"0","endTime":"0","summary":"Generation Income Properties, Inc. , a net lease real estate investment trust, has provided a business update, highlighting recent transactions, operational performance, and strategic alternatives under consideration. The company is exploring a range of options, including a merger, recapitalization, strategic partnerships, or a potential sale. However, no assurances on the outcome or timing of this review have been given, and further comments will only be made once a specific course of action is approved. Despite macroeconomic challenges like elevated interest rates and limited access to public equity capital impacting small publicly traded REITs, GIPR's portfolio remains robust with strong tenant credit quality, 100% rent collection, geographic diversity, and stable cash flows. To enhance financial flexibility, the company is considering refinancing and recapitalizing its preferred equity and asset-level debt, alongside exploring strategic equity capital partnerships. GIPR's Special C","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250630:nNDL61F9ds:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0},{"id":"2546244564","title":"BRIEF-Shareholder Resurgent Realty Trust Says Generation Income Properties Board Should Be Reconstituted","url":"https://stock-news.laohu8.com/highlight/detail?id=2546244564","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2546244564?lang=en_us&edition=fundamental","pubTime":"2025-06-25 23:26","pubTimestamp":1750865200,"startTime":"0","endTime":"0","summary":"BRIEF-Shareholder Resurgent Realty Trust Says Generation Income Properties Board Should Be ReconstitutedJune 25 (Reuters) - Resurgent Realty Trust: SHAREHOLDER RESURGENT REALTY TRUST SAYS GENERATION I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250625:nFWN3SS0I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4160","GIPR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gipreit.com","stockEarnings":[{"period":"1week","weight":-0.341},{"period":"1month","weight":-0.158},{"period":"3month","weight":-0.3466},{"period":"6month","weight":-0.4386},{"period":"1year","weight":-0.5694},{"period":"ytd","weight":-0.5836}],"compareEarnings":[{"period":"1week","weight":-0.0184},{"period":"1month","weight":0.0248},{"period":"3month","weight":0.0192},{"period":"6month","weight":0.1383},{"period":"1year","weight":0.1538},{"period":"ytd","weight":0.1542}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Generation Income Properties, Inc., located in Tampa, Florida, is an internally managed real estate investment trust formed to acquire and own, directly and jointly, real estate investments focused on retail, office, and industrial net lease properties in densely populated submarkets.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.03612},{"month":2,"riseRate":0.5,"avgChangeRate":-0.026285},{"month":3,"riseRate":0.5,"avgChangeRate":-0.00733},{"month":4,"riseRate":0,"avgChangeRate":-0.02411},{"month":5,"riseRate":0.5,"avgChangeRate":0.030613},{"month":6,"riseRate":0,"avgChangeRate":-0.066814},{"month":7,"riseRate":0.25,"avgChangeRate":-0.089889},{"month":8,"riseRate":0.25,"avgChangeRate":-0.101872},{"month":9,"riseRate":0.25,"avgChangeRate":-0.05732},{"month":10,"riseRate":0.25,"avgChangeRate":0.043413},{"month":11,"riseRate":0.2,"avgChangeRate":-0.084843},{"month":12,"riseRate":0,"avgChangeRate":-0.056573}],"exchange":"NASDAQ","name":"Generation Income Properties Inc.","nameEN":"Generation Income Properties Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Generation Income Properties Inc.(GIPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Generation Income Properties Inc.(GIPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Generation Income Properties Inc.,GIPR,Generation Income Properties Inc.股票,Generation Income Properties Inc.股票老虎,Generation Income Properties Inc.股票老虎国际,Generation Income Properties Inc.行情,Generation Income Properties Inc.股票行情,Generation Income Properties Inc.股价,Generation Income Properties Inc.股市,Generation Income Properties Inc.股票价格,Generation Income Properties Inc.股票交易,Generation Income Properties Inc.股票购买,Generation Income Properties Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Generation Income Properties Inc.(GIPR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Generation Income Properties Inc.(GIPR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction